OPK-20018

N/A

Report date: 2025/01/26 17:25:08

Base Information

Drug NameOPK-20018
Drug Alias NameAnti-TNF-alpha biologic (TheraKine)OPK-20018
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsDiabetic macular oedemaUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheraKine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTheraKine Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A